Lord, Abbett & Co’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-212,967
| Closed | -$3.09M | – | 582 |
|
|
2023
Q3 | $3.09M | Sell |
212,967
-152,205
| -42% | -$2.21M | 0.01% | 506 |
|
|
2023
Q2 | $7.64M | Sell |
365,172
-119,494
| -25% | -$2.5M | 0.03% | 442 |
|
|
2023
Q1 | $10.2M | Buy |
484,666
+148,670
| +44% | +$3.14M | 0.04% | 412 |
|
|
2022
Q4 | $8.55M | Buy |
335,996
+1,033
| +0.3% | +$26.3K | 0.03% | 440 |
|
|
2022
Q3 | $8.05M | Buy |
334,963
+20,049
| +6% | +$482K | 0.03% | 428 |
|
|
2022
Q2 | $6.06M | Buy |
314,914
+21,565
| +7% | +$415K | 0.02% | 469 |
|
|
2022
Q1 | $5.1M | Buy |
293,349
+5,297
| +2% | +$92.1K | 0.01% | 545 |
|
|
2021
Q4 | $6.31M | Sell |
288,052
-2,792
| -1% | -$61.1K | 0.01% | 533 |
|
|
2021
Q3 | $5.56M | Sell |
290,844
-3,765
| -1% | -$71.9K | 0.01% | 585 |
|
|
2021
Q2 | $5.06M | Buy |
+294,609
| New | +$5.06M | 0.01% | 609 |
|